Novartis reported CHF13.37B in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14342M 383M
Alcon AG ALC:SW 2.1B 8M
Amgen AMGN:US $ 6706M 180M
AstraZeneca AZN:LN 9866M 1646M
Bayer BAYN:GR € 9781M 1073M
Biogen BIIB:US $ 2778.9M 3.9M
Bristol Myers Squibb BMY:US $ 11624M 79M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Fresenius FRE:GR € 9324M 78M
Fresenius Medical Care FME:GR € 4441M 120.83M
Galapagos GLPG:NA € 76.97M 76.1M
Genmab GEN:DC DK 2310M 338M
Gilead Sciences GILD:US $ 7421M 1204M
GlaxoSmithKline GSK:LN 9077M 985M
GRIFOLS GRF:SM € 1351.9M 167.16M
H. Lundbeck A/S LUN:DC 4.01B 53M
Hikma Pharmaceutical HIK:LN 1.22B 7M
Johnson & Johnson JNJ:US $ 23338M 26M
Lonza Group LONN:SW 2.54B 1.11B
Merck MRK:GR € 4973M 103M
Merk MRK:US $ 13154M 1752M
Novartis NOVN:VX SF 13367M 73M
Novartis NVS:US $ 13367M 73M
Orion ORNBV:FH € 240.9M 14M
Pfizer PFE:US $ 24094M 5117M
Philips PHIA:NA € 4156M 74M
Recordati REC:IM € 385.35M 0.64M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M